Advanced Medical Solutions Group plc

As of December 31, 2025, Advanced Medical Solutions Group plc carries a market capitalization of 536.88M, placing it among publicly traded companies globally. Its enterprise value stands at 611.21M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Advanced Medical Solutions Group plc's next confirmed earnings release is scheduled for March 17, 2027.

As of December 31, 2025, Advanced Medical Solutions Group plc has 216.40M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Advanced Medical Solutions Group plc maintains a current ratio of 2.79, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Advanced Medical Solutions Group plc's stock has gained approximately 31.25% over the past 52 weeks. The 50-day moving average sits at 3.29, while the 200-day moving average is 2.85.

As of December 31, 2025, Advanced Medical Solutions Group plc holds 20.66M in cash and equivalents against 93.49M in total debt, resulting in a net debt position of 57.86M. Total book value stands at 296.78M, with working capital of 102.54M providing operational flexibility.

Advanced Medical Solutions Group plc's most recent stock split took place on April 2, 2002.